<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Leleu, Julie</dc:creator>
  <dc:creator>Simon, Maxime </dc:creator>
  <dc:creator>Cavalcanti Pereira da Silva, Luiz Cesar </dc:creator>
  <dc:creator>Virgilio, Tommaso</dc:creator>
  <dc:creator>De la Garza, Melissa A.</dc:creator>
  <dc:creator>Bakker, Jaco</dc:creator>
  <dc:date>2024</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Rectal prolapse is a common condition in laboratory-housed macaques, usually associated with recurrent gastroenteritis and stress. However, evidence for both statements is lacking. Therefore, the prevalence of rectal prolapses and their risk factors in laboratory-housed macaques have yet to be assessed. In addition, a standard of care pharmacological treatment remains to be recognized and documented. Thus, a retrospective study involving 816 laboratory-housed macaques was conducted, in which the prevalence, risk factors, and treatment success of rectal prolapses was assessed. The prevalence was shown to be 3.92%, and all cases could be either directly or indirectly linked to stress factors. By eliminating the suggested stressor, most rectal prolapses reverted naturally (69%). Moreover, we discuss the advantage of the ancillary administration of hyoscine butylbromide and metamizole as a treatment modality.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/332084</dc:identifier>
  <dc:identifier>https://n2t.net/ark:/12658/srd1332084</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/332084/files/Virgilio_2024_MDPI_laboratories_Rectal prolapse.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/laboratories1030012</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1332084</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Laboratories. - 2024, vol. 1, no. 3, p. 148-157</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Rectal prolapse</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Macaques</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Treatment</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Manual reposition</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Metamizole</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Hyoscine butylbromide</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Prevalence</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Stress</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Etiology</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Risk factor</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns11="xml" ns11:lang="en">Rectal prolapse in laboratory-housed macaques : prevalence, risk factors, and enhanced treatment modality</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
